Longitudinal follow-up of pulmonary, nutritional and laboratory data in patients with cystic fibrosis related diabetes mellitus (CFRD) after initial treatment with glibenclamid

M. Ballmann, C. Mueller-Brandes (Hannover, Germany)

Source: Annual Congress 2003 - Cystic fibrosis: modern methods of monitoring the disease
Session: Cystic fibrosis: modern methods of monitoring the disease
Session type: Poster Discussion
Number: 1535

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
M. Ballmann, C. Mueller-Brandes (Hannover, Germany). Longitudinal follow-up of pulmonary, nutritional and laboratory data in patients with cystic fibrosis related diabetes mellitus (CFRD) after initial treatment with glibenclamid. Eur Respir J 2003; 22: Suppl. 45, 1535

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
The association of pulmonary fibrosis with diabetes mellitus
Source: ERJ Open Res, 6 (4) 00237-2020; 10.1183/23120541.00237-2020
Year: 2020



Role of BMI in the clinical course of COPD patients with type 2 diabetes mellitus
Source: International Congress 2018 – COPD and extrapulmonary comorbidities
Year: 2018


Clinical features of pulmonary tuberculosis in patients with diabetes mellitus
Source: Annual Congress 2012 - Tuberculosis: clinical findings III
Year: 2012


Impact of diabetes mellitus on pulmonary tuberculosis clinical presentation and treatment outcomes
Source: International Congress 2018 – Tuberculosis comorbidities
Year: 2018


Treatment effectiveness among patients with newly detected pulmonary tuberculosis with diabetes mellitus comorbidity
Source: Eur Respir J 2004; 24: Suppl. 48, 653s
Year: 2004

Radiological features of pulmonary tuberculosis in patients with diabetes mellitus
Source: Annual Congress 2011 - Management of tuberculosis
Year: 2011


Improving identification and treatment of children & adolescents with cystic fibrosis related diabetes (CFRD)
Source: Annual Congress 2012 - Cystic fibrosis (adults and children): risk factors and clinical problems
Year: 2012


Newly detected pulmonary tuberculosis in patients combined with diabetes mellitus and without it.
Source: International Congress 2019 – Tuberculosis and comorbidities
Year: 2019


Is there any characteristics difference between pulmonary tuberculosis patients with and without diabetes mellitus type 2?
Source: Annual Congress 2009 - Tuberculosis: metabolism and comorbidities
Year: 2009

Study of pulmonary function in type2 diabetes mellitus and its changes with change in duration and glycemic control
Source: Annual Congress 2012 - Pathophysiological mechanisms in disease: new insights
Year: 2012

Peculiarities of diabetes mellitus in cystic fibrosis adults
Source: Annual Congress 2010 - New aspects of cystic fibrosis
Year: 2010


Late Breaking Abstract - The cost, health resources utilization and medications in chronic obstructive pulmonary patients with diabetes mellitus: a population-based cohort study in Taiwan.
Source: International Congress 2019 – COPD treatment: cardiovascular, oxygen and vaccination studies
Year: 2019


Effect of ICS on glycaemic control in patients with COPD and comorbid type 2 diabetes: Historical case-matched cohort study
Source: International Congress 2016 – Managing multimorbidity and lifestyle change in primary care
Year: 2016


Presentations and treatment response of pulmonary tuberculosis in type 2 diabetes mellitus
Source: Annual Congress 2012 - Tuberculosis: clinical findings II
Year: 2012


Intensive chemotherapy of pulmonary tuberculosis in patients with diabetes mellitus
Source: Eur Respir J 2004; 24: Suppl. 48, 648s
Year: 2004

New criteria for impaired fasting glucose and screening for diabetes in cystic fibrosis
Source: Eur Respir J 2005; 25: 715-717
Year: 2005



To improvement of diagnostics of the diabetes mellitus 2 type at patients with chronic obstructive pathology of lungs
Source: International Congress 2014 – COPD: points to ponder
Year: 2014

Decline of the lung function and quality of glycemic control in type 2 diabetes mellitus
Source: Annual Congress 2013 –Novel biomarkers and old parameters in clinical management of lung diseases
Year: 2013


Increased augmentation index in patients with cystic fibrosis
Source: Eur Respir J 2009; 34: 1322-1328
Year: 2009



Impact of diabetes mellitus on clinical parameters and treatment outcomes of diagnosed pulmonary tuberculosis patients
Source: International Congress 2014 – Tuberculosis: from epidemiology to therapy 1
Year: 2014